Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women

Carcinogenesis

Volumn 27, Issue 6, 2006, Pages 1240-1244

  Seow, Adeline ^a   Ng, Daniel P K ^a   Choo, Serena ^a   Eng, Philip ^b   Poh, Wee Teng ^c   Ming, Teh ^a   Wang, Yee Tang ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c CHANGI GENERAL HOSPITAL   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOSINE; GUANINE; INTERLEUKIN 6;

ADENOCARCINOMA; ADULT; ARTICLE; ASIAN; ASTHMA; ATOPY; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CHRONIC INFLAMMATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL ANALYSIS;

AGED; ASTHMA; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION; INTERLEUKIN-6; LUNG NEOPLASMS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; SMOKING;

EID: 33745610052     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi309     Document Type: Article

References (61)

1. Balkwill,F. and Mantovani,A. (2001) Inflammation and cancer: Back to Virchow? Lancet, 357, 539-545.
2. Fitzpatrick,F.A. (2001) Inflammation, carcinogenesis and cancer. Int. Immunopharmacol., 1, 1651-1667.
3. Ohshima,H., Tatemichi,M. and Sawa,T. (2003) Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys., 417, 3-11.
4. Ohshima,H., Tazawa,H., Sylla,B.S. and Sawa,T. (2005) Prevention of human cancer by modulation of chronic inflammatory processes. Mutation Res., 591, 110-122.
5. Asselin-Paturel,C., Echchakir,H., Caroyol,G., Gay,F., Opolon,P., Grunenwald,D. Chouaib,S. and Mami-Chouaib,F. (1998) Quantitative analysis of Th1, Th2 and TGF-β1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int. J. Cancer, 77, 7-12.
6. Wolff,H., Saukkonen,K., Anttila,S., Karjalainen,A., Vainio,H. and Ristimaki,A. (1998) Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58, 4997-5001.
7. Hida,T., Yatabe,Y., Achiwa,H., Muramatsu,H., Kozaki,K., Nakamura,S., Ogawa,M., Mitsudomi,T., Sugiura,T. and Takahashi,T. (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58, 3761-3764.
8. Campa,D., Zienolddiny,S., Maggini,V., Skaug,V., Haugen,A. and Canzian,F. (2004) Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis, 25, 229-235.
9. Martey,C.A., Pollock,S.J., Turner,C.K., O'Reilly,K.A., Baglole,C.J., Phipps,R.P. and Sime,P.J. (2004) Cigarette smoke induces cyclooxygenase-2 and microsomal psotaglandin E2 synthase in human lung fibroblasts: Implications for lung inflammation and cancer. Am. J. Physiol. Lung Cell. Mol. Physiol., 287, 981-991.
10. Le Calvez,F., Mukeria,A., Hunt,J.D., Kelm,O., Hung,R.J., Taniere,P., Brennan,P., Boffetta,P., Zaridze,D.G. and Hainaut,P. (2005) TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: Distinct patterns in never, former, and current smokers. Cancer Res., 65, 5076-5083.
11. Wu,A.H., Yu,M.C., Thomas,D.C., Pike,M.C. and Henderson,B.E. (1998) Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res., 48, 7279-7284.
12. Alavanja,M.C.R., Brownson,R.C., Boice,J.D. and Hock,E. (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am. J. Epidemiol., 136, 623-632.
13. Mayne,S.T., Buenconsejo,J. and Janerich,D.T. (1999) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am. J. Epidemiol., 149, 13-20.
14. Wu-Williams,A.H., Dai,X.D., Blot,W. et al. (1990) Lung cancer among women in north-cast China. Br. J. Cancer, 62, 982-987.
15. Brenner,A.V., Wang,Z., Kleinerman,R.A., Wang,L., Zhang,S., Metayer,C., Chen,K., Lei,S., Cui,H. and Lubin,J.H. (2001) Previous pulmonary diseases and risk of lung cancer in Gansu Porvince, China. Int. J. Epidemiol., 30, 118-124.
16. Novak,J. and Bieber,T. (2003) Allergic and nonallergic forms of atopic diseases. J. Allergy Clin. Immunol., 112, 252-262.
17. Barnes,P.J. (1996) Pathophysiology of asthma. Br. J. Clin. Pharmacol., 42, 3-10
18. Togias,A. (2001) Systemic cross-talk between the lung and the nose. Am. J. Resp. Crit. Care Med., 164, 726-727.
19. Venge,P. (2004) Monitoring the allergic inflammation. Allergy, 59, 26-32.
20. Boguniewicz,M. (2005) Atopic dematitis: Beyond the itch that rashes. Immunol. Allergy Clin. N. Am., 25, 333-351.
21. Spergel,J.M. and Paller,A.S. (2003) Atopic dermatitis and the atopic march. J. Allergy Clin. Immunol., 12, S118-127.
22. Santillan,A.A., Camargo,C.A. and Colditz,G.A. (2003) A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control, 14, 327-334.
23. Wang,H. and Diepgen,T.L.(2005) Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy, 60, 1098-1111.
24. Hirano,T. (1992) Interleukin-6 and its relation to inflammation and disease. Clin. Immunol. Immunopath., 62, S60-65.
25. Coussens,L.M. and Werb,Z. (2002) Inflammation and cancer. Nature, 420, 860-867.
26. Ardies,C.M. (2003) Inflammation as a cause for scar cancers of the lung. Integrative Cancer Ther., 2, 238-246.
27. Wiseman,H. and Halliwell,B. (1996) Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem. J., 313, 17-29.
28. Matanic,D., Beg-Zec,Z., Stojanovic,D., Matakoric-Mileusnic,N., Flego,V. and Milevoj-Ribic,F. (2003) Cytokines in patients with lung cancer. Scand. J. Immunol., 57, 173-178.
29. Dowlati,A., Levitan,N. and Remick,S.C. (1999) Evaluation of interleukin-6 in bronchoalveolar lavage fluid and serum of patients with lung cancer. J. Lab. Clin. Med., 134, 405-409.
30. Brichory,F.M., Misek,D.E., Yim,A., Krause,M.C., Giodano,T.J., Beer,D.G. and Hanash,S.M. (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl Acad. Sci. USA, 98, 9824-9829.
31. McKeown,D.J., Brown,D.J.F., Kelly,A., Wallace,A.M. and McMillan,D.C. (2004) The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small cell lung cancer. Br. J. Cancer, 91, 1993-1995.
32. Bennermo,M., Held,C., Stemme,S., Ericsson,C., Silveira,A., Green,F. and Tornvall,P. (2004) Genetic predisposition of the interleukin-6 response to inflammation: Implications for a variety of major diseases? Clin. Chem., 50, 2136-2140.
33. Terry,C.F., Loukaci,V. and Green,F.R. (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem., 275, 18138-18144.
34. Zhai,R., Liu,G., Yang,C., Huang,C., Wu,C. and Christiani,D.C. (2001) The G to C polymorphism at - 174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics, 11, 699-701.
35. Lim,C.S., Zheng,S., Kim,Y.S., Ahn,C., Han,J.S., Kim,S., Lee,J.S. and Chae,D. (2002) The -174 G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine, 19, 52-54.
36. Nakajima,T., Ota,N., Yoshida,H., Watanabe,S., Suzuki,T. and Emi,M. (1999) Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun., 1, 115-119.
37. Kitamura,A., Hasegawa,G., Obayashi,H. et al. (2002) Interleukin-6 polymorphism (-634 C/G) in the promoter region and the progression of diabetic nephropathy in Type 2 diabetes. Diabet. Med., 19, 1000-1005.
38. Seow,A., Poh,W.T., Teh,M., Eng,P., Wang,Y.T., Tan,W.C., Yu,M.C. and Lee,H.P. (2000) Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol. Biomark. Prev., 9, 1215-1221.
39. Towner,P. Purification of DNA. In: Brown,T.A. (ed) Essential Molecular Biology Vol 1, A Practical Approach. Oxford University Press, New York, NY, pp. 47-69.
40. Boulay,M. and Boulet,L. (2003) The relationships between atopy, rhinitis and asthma: Pathophysiological considerations. Curr. Opin. Allergy Clin. Immunol., 3, 51-55.
41. Leung,D.Y.M., Boguniewicz,M., Howell,M.D., Nomura,K. and Hamid,Q.A. (2004) New insights into atopic dermatitis. J. Clin. Invest., 113, 651-657.
42. Spergel,J.M., Mizoguchi,E., Brewer,J.P., Martin,T.R., Bhan,A.K. and Geha,R.S. (1998) Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin, Invest., 8, 1614-1622.
43. Kidon,M.I., Chiang,W.C., Liew,W.K., Lim,S.H., See,Y., Goh,A., Tan,J.P.L., Chay,O.M. and Balakrishnan,A. (2005) Sensitization to dust mites in children with allergic rhinitis in Singapore: Does it matter if you scratch while you sneeze? Clin. Exp. Allergy, 35, 434-440.
44. Heinzmann,A. and Deichmann,K.A. (2001) Genes for atopy and asthma. Curr. Opin. Allergy Clin. Immunol., 1, 387-392.
45. Bucchieri,F., Puddicombe,S.M., Lodan,J.L. et al. (2002) Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am. J. Respir. Cell. Mol. Biol., 27, 179-185.
46. Turner,M.C., Chen,Y., Krewski,D., Ghadirian,P., Thun,M.J. and Calle,E.E. (2005) Cancer mortality among US men and women with asthma and hay fever. Am. J. Epidemiol., 162, 212-221.
47. Lange,P., Ulrik,C.S. and Vestbo,J. (1996) Mortality in adults with self-reported asthma. Lancet, 347, 1285-1289.
48. Versterinen,E., Pukkala,E., Timonen,T. and Aromaa,A. (1993) Cancer incidence among 78 000 asthmatic patients. Int. J. Epidemiol., 22, 976-982.
49. Vandentorren,S., Baldi,I., Maesano,I.A., Charpin,D., Neukirch,F., Filleul,L., Cantagrel,A. and Tessier,J.F. (2003) Long-term mortality among adults with or without asthma in the PAARC study. Eur. Respir. J., 21, 462-467.
50. Boffetta,P., Ye,W., Boman,G. and Nyren,O. (2002) Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur. Respir. J., 19, 127-133.
51. Vena,J.E., Bona,J.R., Byers,T.E., Middleton,E.Jr, Swanson,M.K. and Graham,S. (1985) Allergy-related diseases and cancer: An inverse association. Am. J. Epidemiol., 122, 66-74.
52. Sanchez-Borges,M., De Orozco,A., Arellano,S., De Gallego,V., Avila-Millian,E. and Suarez-Chacon,R. (1986) Preventive role of atopy in lung cancer. Clin. Immunol. Imunopath., 41, 314-319.
53. Schabath,M.B., Delclos,G.L., Martynowicz,M.M., Greisinger,A.J., Lu,C., Wu,X. and Spitz,M.R. (2005) Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am. J. Epidemiol., 161, 412-422.
54. Talbot-Smith,A., Fritshci,L., Divitini,M.L., Mallon,D.F.J. and Knuiman,M.W. (2003) Allergy, atopy and cancer: A prospective study of the 1981 Busselton cohort. Am. J. Epidemiol., 157, 606-612.
55. Kosaka,T., Yatabe,Y., Endoh,H., Kuwano,H., Takahashi,T. and Mitsudomi,T. (2004) Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications. Cancer Res., 64, 8919-8923.
56. Shigematsu,H., Lin,L., Takahashi,T. et al. (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J. Natl Cancer Inst., 97, 339-346.
57. Salomon,D.S., Brandt,R., Ciardiello,F. and Normanno,N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Onc. Haem., 19, 183-232.
58. Amishima,M., Munakata,M., Nasuhara,Y., Sato,A., Takahashi,T., Homma,Y. and Kawakami,Y. (1998) Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am. J. Respir. Crit. Care Med., 157, 1907-1912.
59. Wong,W.S.F. (2005) Inhibitors of the tyrosine kinase signalling cascade for asthma. Curr. Opin. Pharmacol., 5, 264-271.
60. Holgate,S.T., Lackie,P.M., Davies,D.E., Roche,W.R. and Walls,A.F. (1999) The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin. Exp. Allergy, 29, 90-95.
61. Hamilton,M.L., Puddicombe,S.M., Dearman,R.J., Kimber,I., Sandstrom,T., Wallin,A., Howarth,P.H., Holgate,S.T., Wilson,S.J. and Davies,D.E. (2005) Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur. Respir. J., 25, 978-985.